← Back to Clinical Trials
Recruiting NCT05647135

NCT05647135 ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05647135
Status Recruiting
Phase
Sponsor Romanian Society for Enteral and Parenteral Nutrition
Condition Metabolism
Study Type OBSERVATIONAL
Enrollment 70 participants
Start Date 2023-03-01
Primary Completion 2024-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Medical food

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 70 participants in total. It began in 2023-03-01 with a primary completion date of 2024-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content. * Differences regarding achieving protein and calorie daily targets when using enteral nutrition formulas with different protein content * Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content * Differences regarding body composition when using enteral nutrition formulas with different protein content

Eligibility Criteria

Inclusion Criteria: * Adult patients (\>18 yrs) admitted to the ICU * Multiple trauma (Injury severity score \> 18) * Intubation and mechanical ventilation upon admission in ICU or during the first 24 hours of admission, for at least 48 h Exclusion Criteria: * Age \< 18 years * Pregnant women * Patients not intubated or not mechanically ventilated or receiving only non-invasive ventilation * Patients with enteral feeding contraindication 48 h after admission * Patients with recent gastrointestinal surgical intervention * Patients on chronic therapy with corticosteroids

Contact & Investigator

Central Contact

Ioana Grintescu, MD, PhD

✉ ioana.grintescu@rospen.ro

📞 +40722329187

Principal Investigator

Ioana Grintescu, MD, PhD

STUDY DIRECTOR

Romanian Society of Enteral and Parenteral Nutrition

Frequently Asked Questions

Who can join the NCT05647135 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Metabolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05647135 currently recruiting?

Yes, NCT05647135 is actively recruiting participants. Contact the research team at ioana.grintescu@rospen.ro for enrollment information.

Where is the NCT05647135 trial being conducted?

This trial is being conducted at Bucharest, Romania.

Who is sponsoring the NCT05647135 clinical trial?

NCT05647135 is sponsored by Romanian Society for Enteral and Parenteral Nutrition. The principal investigator is Ioana Grintescu, MD, PhD at Romanian Society of Enteral and Parenteral Nutrition. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology